CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Dec. 31, 2021	Mar. 31, 2021
Current assets
Cash	$ 20,394,536	$ 9,861,575
Accounts receivable	131,966	149,082
Prepaid expenses and other current assets	683,722	341,081
Total current assets	21,210,224	10,351,738
Property and equipment, net	254,024	160,976
Right-of-use lease asset	328,869	40,363
Patents, net	2,338	56,954
Restricted cash	87,506	46,726
Deposits	33,305	12,159
Total assets	21,916,266	10,668,916
Current liabilities
Accounts payable	234,118	337,678
Due to related parties	130,375	118,520
Deferred revenue	229,698	114,849
Lease liability, current portion	53,545	42,543
Other current liabilities	421,956	761,636
Total current liabilities	1,069,692	1,375,226
Lease liability, less current portion	287,221
Total liabilities	1,356,913	1,375,226
Stockholders’ Equity
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 15,408,231 and 12,150,597 shares issued and outstanding as of December 31, 2021 and March 31, 2021, respectively	15,410	12,152
Additional paid-in capital	147,229,134	129,331,542
Accumulated deficit	(126,544,103)	(119,913,090)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests	20,700,441	9,430,604
Noncontrolling interests	(141,088)	(136,914)
Total stockholders’ equity	20,559,353	9,293,690
Total liabilities and stockholders’ equity	$ 21,916,266	$ 10,668,916